S100B blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study

Abstract

Serum S100B level on admission of patients with MHI is an accurate and useful screening tool to exclude intracranial lesions. Performing a second late S100B level determination is not informative. The two automated immunoassays appear usable in a similar manner, although the two methods are not interchangeable.